|Bid||5.00 x 1400|
|Ask||5.98 x 900|
|Day's range||5.81 - 6.33|
|52-week range||4.77 - 29.81|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||09 May 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||10.00|
Joining me today are Mike Lester, chief executive officer; Mike Bruff, chief financial officer; and Danish Qureshi, chief growth officer. Both are available on the Investor Relations section of our website, investor.lifestance.com.
Image source: The Motley Fool. LifeStance Health Group, Inc. (NASDAQ: LFST)Q4 2021 Earnings CallMar 10, 2022, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and thank you for standing by.
NEW YORK, November 18, 2021--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against LifeStance Health Group ("LifeStance" or the "Company") (NASDAQ: LFST) on behalf of LifeStance stockholders. Our investigation concerns whether LifeStance has violated the federal securities laws and/or engaged in other unlawful business practices.